Article Types

Research

Trauma‐related admissions to intensive care units in Australia: the influence of Indigenous status on outcomes

Objectives: To investigate the admission characteristics and hospital outcomes for Indigenous and non‐Indigenous patients admitted to intensive units (ICUs) after major trauma. Design, setting: Retrospective analysis of Australian and New Zealand Intensive Care Society (ANZICS) Adult Patient Database data from 92 Australian ICUs for the 6‐year period, 2010–2015. Participants: Patients older than 17 years of age admitted to public hospital ICUs with a primary diagnosis of trauma. Main outcome measures: ICU and overall hospital lengths of stay, hospital discharge destination, and ICU and overall hospital mortality rates for Indigenous and non‐Indigenous patients. Results: 23 804 people were admitted to Australian public hospital ICUs after major trauma; 1754 (7.4%) were Indigenous Australians. The population‐standardised incidence of admissions was consistently higher for Indigenous Australians than for non‐Indigenous Australians (847 per million v 251 per million population; incidence ratio, 3.37; 95% CI, 3.19–3.57). Overall hospital mortality rates were similar for Indigenous and non‐Indigenous patients (adjusted odds ratio [aOR], 1.04; 95% CI, 0.82–1.31). Indigenous patients were more likely than non‐Indigenous patients to be discharged to another hospital (non‐Indigenous v Indigenous: aOR, 0.84; 95% CI, 0.72–0.96) less likely to be discharged home (non‐Indigenous v Indigenous: aOR, 1.17; 95% CI, 1.04–1.31). Conclusion: The population rate of trauma‐related ICU admissions was substantially higher for Indigenous than non‐Indigenous patients, but hospital mortality rates after ICU admission were similar. Indigenous patients were more likely to be discharged to a another hospital and less likely to be discharged home than non‐Indigenous patients.

Fraser Magee · Anthony Wilson · Michael J Bailey · David Pilcher · Paul J Secombe · Paul Young · Rinaldo Bellomo

Mja2 12028
Statistics Research 29 April 2019 Free

Evaluating recruitment strategies for AUSPICE, a large Australian community‐based randomised controlled trial

Novel, multifaceted recruitment methods are needed to obtain adequate participation in Australian randomised controlled trials

Roseanne Peel · Shu Ren · Alexis Hure · Tiffany‐Jane Evans · Catherine A D'Este · Walter P Abhayaratna · Andrew M Tonkin · Ingrid Hopper · Amanda G Thrift · Christopher R Levi · Jonathan Sturm · David Durrheim · Joseph Hung · Tom G Briffa · Derek P Chew · Phil Anderson · Lynelle Moon · Mark McEvoy · Philip M Hansbro · David A Newby · John R Attia

Mja2 50117

Early initiation of antiretroviral therapy for people newly diagnosed with HIV infection in Australia: trends and predictors, 2004–2015

The known Treatment of people infected with human immunodeficiency virus (HIV) soon after diagnosis reduces the risk of transmission and HIV‐related morbidity. The proportion and characteristics of people who receive early treatment are not well described.

Hamish McManus · Denton Callander · Basil Donovan · Darren B Russell · Catherine C O'Connor · Stephen C Davies · David A Lewis · Margaret E Hellard · Marcus Y Chen · Kathy Petoumenos · Rick Varma · Aaron Cogle · Mark Alastair Boyd · Andrew Grulich · James Pollard · Nick Medland · Christopher K Fairley · Rebecca J Guy

Mja2 50006

Cultural respect in general practice: a cluster randomised controlled trial

The known: The gap in life expectancy between Indigenous and non‐Indigenous Australians remains large. Urban Indigenous Australian‐controlled health services are under‐resourced, and mainstream primary care services are often not culturally sensitive.

Siaw‐Teng Liaw · Vicki Wade · John S Furler · Iqbal Hasan · Phyllis Lau · Margaret Kelaher · Wei Xuan · Mark F Harris

Mja2 50031

The burden of pancreatic cancer in Australia attributable to smoking

The knownThe future pancreatic cancer burden attributable to tobacco smoking has not been estimated in Australia. The newNearly 22% of the future burden of pancreatic cancer is attributable to current and former smoking, 15% (5500 cases over the next 10 years) to current smoking alone. The smoking‐related burden of pancreatic cancer is markedly higher for men and for people under 65. The implicationsReducing smoking rates among men and people under 65 would have the greatest impact on reducing the future burden of pancreatic cancer in Australia.

Maria E Arriaga · Claire M Vajdic · Robert J MacInnis · Karen Canfell · Dianna J Magliano · Jonathan E Shaw · Julie E Byles · Graham G Giles · Anne W Taylor · Tiffany K Gill · Vasant Hirani · Robert G Cumming · R Paul Mitchell · Emily Banks · Julie Marker · Barbara‐Ann Adelstein · Maarit A Laaksonen

Mja2 12108

Subscribe to MJA email alerts

No spam, you can unsubscribe anytime you want.

By providing your information, you agree to our Terms of Use and our Privacy Policy.

Thanks for Subscribing! Tell us more

Your email updates will use your name.

Good one! Your updates are coming

Thank you for subscribing to the MJA email alerts. Receive the latest content in your inbox.